Jin-Kyoung Shim

5PUBLICATIONS
33CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Regenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 08, 2026
IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation.

Jung Won Park, Jiehoon Kwak, Keon-Woo Kim

|Feb 24, 2023
Mesenchymal Stem-Like Cells Derived from the Ventricle More Effectively Enhance Invasiveness of Glioblastoma Than Those Derived from the Tumor.

Junseong Park, Dongkyu Lee, Jin-Kyoung Shim

|Oct 11, 2022
Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres.

Jin-Kyoung Shim, Seonah Choi, Seon-Jin Yoon

|Sep 24, 2021
Influence of the Amount of Fresh Specimen on the Isolation of Tumor Mesenchymal Stem-Like Cells from High-Grade Glioma.

Soon Haeng Kong, Jihwan Yoo, Dongkyu Lee

|Mar 17, 2016
Tumor Mesenchymal Stem-Like Cell as a Prognostic Marker in Primary Glioblastoma.

Seon-Jin Yoon, Jin-Kyoung Shim, Jong Hee Chang

Pageof 1

Frequent Collaborators

4 joint publications

Seok-Gu Kang

4 joint publications

Jong Hee Chang

4 joint publications

Eui-Hyun Kim

2 joint publications

Junseong Park